Mathis Planert
Papers
1
Total Citations
30
H-Index
1
About
Dr. Mathis Planert is a pioneering interventional oncologist whose research centers on the development and clinical translation of non-invasive tumor ablation technologies, particularly histotripsy. As the lead author of the landmark "#HOPE4LIVER Single-arm Pivotal Trial for Histotripsy of Primary and Metastatic Liver Tumors" (2025, 30 citations), Dr. Planert has fundamentally advanced the field of focused ultrasound therapy. This pivotal study provided the first robust 1-year clinical outcomes demonstrating that histotripsy—a novel, non-thermal, non-invasive technique that mechanically liquefies tissue using focused ultrasound—can safely and effectively treat both primary and metastatic liver tumors. The work represents a paradigm shift from traditional thermal ablation, offering a scarless, radiation-free alternative with potential for precise tumor destruction while preserving surrounding healthy liver parenchyma. Dr. Planert's contributions are particularly significant given the rising global burden of liver cancer, and the #HOPE4LIVER trial has established a new benchmark for non-invasive oncologic interventions. With a rapidly growing citation impact, Dr. Planert is widely recognized as a leading voice in therapeutic ultrasound, and their ongoing research continues to expand the boundaries of image-guided, incisionless cancer therapy.
Research Focus
Key Achievements
Top Papers
- 1